A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)Eleni Josephides, Eleni Karapanagiotou, Maria J. Monroy‐Iglesias et al.|Clinical Lung Cancer|2025Cited by 5
Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer: A multi-centre retrospective analysis.Sarah Hunter, Eleni Karapanagiotou, Guillermina Nickless et al.|Journal of Clinical Oncology|2017Cited by 1
63: Crizotinib for ALK rearrangement in non small cell lung cancerS. Merrick, Sunita Ghosh, Sarah Hunter et al.|Lung Cancer|2017Cited by 0
72: Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancerSarah Hunter, Eleni Karapanagiotou, Guillermina Nickless et al.|Lung Cancer|2017Cited by 0
A Retrospective Evaluation of Pd-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (Replica)Eleni Josephides, Eleni Karapanagiotou, Andrea Billè et al.|SSRN Electronic Journal|2024Cited by 0